Edwards Lifesciences (EW) - Stock & Dividends

Edwards Lifesciences Corp (NYSE:EW) is a company that specializes in providing innovative products and technologies for structural heart disease and critical care monitoring. Operating not only in the United States but also in Europe, Japan, and across the globe, their wide range of solutions cater to various heart conditions.

One of their notable offerings is the transcatheter heart valve replacement products from the Edwards SAPIEN family, which are designed for minimally invasive procedures to replace aortic heart valves. They also offer transcatheter heart valve repair and replacement products under different names like PASCAL PRECISION and Cardioband, which target mitral and tricuspid valve diseases.

Moreover, Edwards Lifesciences Corp provides surgical structural heart solutions, including products like the aortic surgical valve called INSPIRIS and innovative options like INSPIRIS RESILLA aortic valve with RESILIA tissue and VFit technology. Their critical care solutions are equally impressive, featuring hemodynamic monitoring systems such as FloTrac and ClearSight to assess a patient's heart function and fluid status.

Established in 1958 and headquartered in Irvine, California, Edwards Lifesciences Corp operates with direct sales teams and independent distributors worldwide to ensure their products reach those in need. To learn more about their offerings, visit their website at https://www.edwards.com.